Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.5 USD | -0.66% | -11.03% | -11.14% |
Apr. 02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
Apr. 02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
Business Summary
Number of employees: 162
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Gene Therapies
100.0
%
| 41 | 100.0 % | 250 | 100.0 % | +511.16% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 250 | 100.0 % | +511.16% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 22-02-28 |
Michael Higgins
CHM | Chairman | 61 | 15-07-21 |
Director of Finance/CFO | 55 | 22-09-18 | |
Todd Carter
CTO | Chief Tech/Sci/R&D Officer | 54 | 18-10-31 |
Robin Swartz
COO | Chief Operating Officer | 53 | 21-08-31 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 17-01-04 |
James Geraghty
BRD | Director/Board Member | 70 | 13-12-31 |
Beth Shafer
PRN | Corporate Officer/Principal | - | 23-08-06 |
Human Resources Officer | - | 20-09-13 | |
General Counsel | - | 23-07-09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 23-05-08 |
James Geraghty
BRD | Director/Board Member | 70 | 13-12-31 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 17-01-04 |
Catherine Mackey
BRD | Director/Board Member | 68 | 22-08-14 |
Steven E. Hyman
BRD | Director/Board Member | 71 | 15-09-16 |
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 22-02-28 |
Grace E. Colón
BRD | Director/Board Member | 57 | 22-12-31 |
Nancy J. Vitale
BRD | Director/Board Member | - | 20-09-14 |
Michael Higgins
CHM | Chairman | 61 | 15-07-21 |
Jude Onyia
BRD | Director/Board Member | 60 | 23-02-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,300,627 | 44,912,750 ( 82.71 %) | 0 | 82.71 % |
Company contact information
Voyager Therapeutics, Inc.
75 Hayden Avenue
02421, Lexington
+857 259 5340
http://www.voyagertherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.14% | 410M | |
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |
- Stock Market
- Equities
- VYGR Stock
- Company Voyager Therapeutics, Inc.